The Precision Medicine Initiative's All of Us Research Program: an agenda for research on its ethical, legal, and social issues.
paper
Cited
Public
Unavailable
- Authors
- Sankar, Pamela L; Parker, Lisa S
- Year
- 2017
- Journal
- Genetics in medicine : official journal of the American College of Medical Genetics
- PMID
- 27929525
- DOI
- 10.1038/gim.2016.183
The Precision Medicine Initiative (PMI) is an innovative approach to developing a new model of health care that takes into account individual differences in people's genes, environments, and lifestyles. A cornerstone of the initiative is the PMI All of Us Research Program (formerly known as PMI-Cohort Program) which will create a cohort of 1 million volunteers who will contribute their health data and biospecimens to a centralized national database to support precision medicine research. The PMI All of US Research Program is the largest longitudinal study in the history of the United States. The designers of the Program anticipated and addressed some of the ethical, legal, and social issues (ELSI) associated with the initiative. To date, however, there is no plan to call for research regarding ELSI associated with the Program-PMI All of Us program. Based on analysis of National Institutes of Health (NIH) funding announcements for the PMI All of Us program, we have identified three ELSI themes: cohort diversity and health disparities, participant engagement, and privacy and security. We review All of Us Research Program plans to address these issues and then identify additional ELSI within each domain that warrant ongoing investigation as the All of Us Research Program develops. We conclude that PMI's All of Us Research Program represents a significant opportunity and obligation to identify, analyze, and respond to ELSI, and we call on the PMI to initiate a research program capable of taking on these challenges.Genet Med advance online publication 01 December 2016.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Conclusion: Special issue on genetic and alcohol use disorder research with diverse racial/ethnic groups: Key findings and potential next steps. | 2017 | 28745446 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Designing a Digital Twin for the Management of Noncommunicable Diseases: Protocol for a Pilot Study and Methodology Validation. | Ross E et al. | β | 2026 | β |
| Health outcomes after national acute sleep deprivation events among the American public. | Kelly NJ et al. | β | 2026 | β |
| Integration of modern technologies to advance dietary assessment. | Cuparencu C et al. | β | 2026 | β |
| Predicting incident type 2 diabetes using wearable activity and polygenic risk: A survival-modeling study in All of Us. | Rahman MH et al. | β | 2026 | β |
| Returning value to communities from the All of Us Research Program through the lens of social determinants of health and ethical, legal, and social implications. | Hashish MA et al. | β | 2026 | β |
| Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice. | Yoshida T et al. | β | 2025 | β |
| Are Hospital Pharmacists Ready for Precision Medicine in Nigerian Healthcare? Insights From a Multi-Center Study. | Nwokebu GC et al. | β | 2025 | β |
| Associations between Class I, II, or III Obesity and Health Outcomes. | Yao Z et al. | β | 2025 | β |
| Computational strategic recruitment for representation and coverage studied in the All of Us Research Program. | Borza VA et al. | β | 2025 | β |
| Ethical disclosure of biomarkers for Alzheimer risk in Latin American participants. | Oviedo DC et al. | β | 2025 | β |
| Identifying High-Priority Ethical Challenges for Precision Emergency Medicine: Nominal Group Study. | Rose C et al. | β | 2025 | β |
| Liquid Biopsy: The Challenges of a Revolutionary Approach in Oncology. | Coppola CA et al. | β | 2025 | β |
| Personalized medicine and health equity: overcoming cost barriers and ethical challenges. | Francisco KKY et al. | β | 2025 | β |
| Religious factors predict support for genomic medicine more strongly than politics, education, or trust: A survey of 4,939 adults in the United States. | DuBois JM et al. | β | 2025 | β |
| Sociodemographically differential patterns of chronic pain progression revealed by analyzing the all of us research program data. | Baldwin E et al. | β | 2025 | β |
| The Era of Preemptive Medicine: Developing Medical Digital Twins through Omics, IoT, and AI Integration. | Ooka T | β | 2025 | β |
| The Public Knowledge of Precision Medicine and Genomic Research: A Survey in the Aosta Valley. | Mongelli M et al. | β | 2025 | β |
| Twenty-Five Years of Evolution and Hurdles in Electronic Health Records and Interoperability in Medical Research: Comprehensive Review. | Shen Y et al. | β | 2025 | β |
| Unveiling the Disparities in the Field of Precision Medicine: A Perspective. | Morsi MH et al. | β | 2025 | β |
| Beyond the Human Genome Project: The Age of Complete Human Genome Sequences and Pangenome References. | Taylor DJ et al. | β | 2024 | β |
| Multi-modality risk prediction of cardiovascular diseases for breast cancer cohort in the All of Us Research Program. | Yang H et al. | β | 2024 | β |
| OHDSI Standardized Vocabularies-a large-scale centralized reference ontology for international data harmonization. | Reich C et al. | β | 2024 | β |
| Opportunities for predictive proteogenomic biomarkers of drug treatment sensitivity in epithelial ovarian cancer. | Philips TJ et al. | β | 2024 | β |
| [Precision medicine in rehabilitation settings]. | DΓ‘valos-Yerovi V et al. | β | 2024 | β |
| The interrelation of scientific, ethical, and translational challenges for precision medicine with multimodal biomarkers - A qualitative expert interview study in dermatology research. | Hangel N et al. | β | 2024 | β |
| The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine. | Hashimoto T et al. | β | 2024 | β |
| Using patient portals for large-scale recruitment of individuals underrepresented in biomedical research: an evaluation of engagement patterns throughout the patient portal recruitment process at a single site within the All of Us Research Program. | Beaton M et al. | β | 2024 | β |
| 3D Printing Technology as a Promising Tool to Design Nanomedicine-Based Solid Dosage Forms: Contemporary Research and Future Scope. | Ahmad J et al. | β | 2023 | β |
| A Primer in Precision Nephrology: Optimizing Outcomes in Kidney Health and Disease through Data-Driven Medicine. | Jayaraman P et al. | β | 2023 | β |
| Assessing the role of interactivity: An evaluation of information aids to support the enrollment of precision medicine research programs. | Peng W et al. | β | 2023 | β |
| Big data from small animals: integrating multi-level environmental data into the Dog Aging Project. | Xue D et al. | β | 2023 | β |
| Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias. | Hu WT et al. | β | 2023 | β |
| Comparison of Methods for Biological Sequence Clustering. | Wei ZG et al. | β | 2023 | β |
| Data Science and Precision Oncology Nursing: Creating an Analytic Ecosystem to Support Personalized Supportive Care across the Trajectory of Illness. | Keim-Malpass J et al. | β | 2023 | β |
| From target discovery to clinical drug development with human genetics. | Trajanoska K et al. | β | 2023 | β |
| Image-guided cancer surgery: a narrative review on imaging modalities and emerging nanotechnology strategies. | Bortot B et al. | β | 2023 | β |
| Managing re-identification risks while providing access to the All of Us research program. | Xia W et al. | β | 2023 | β |
| Mapping uncertainty in precision medicine: A systematic scoping review. | Lohse S | β | 2023 | β |
| Neural systems underlying RDoC social constructs: An activation likelihood estimation meta-analysis. | Pintos Lobo R et al. | β | 2023 | β |
| Public perceptions and attitudes of the national project of bio-big data: A nationwide survey in the Republic of Korea. | Yang JH et al. | β | 2023 | β |
| Single Nucleotide Polymorphism rs9277336 Controls the Nuclear Alpha Actinin 4-Human Leukocyte Antigen-DPA1 Axis and Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension. | Hafeez N et al. | β | 2023 | β |
| Successes and challenges of artificial intelligence in cardiology. | Vandenberk B et al. | β | 2023 | β |
| TARGETING UNDERREPRESENTED POPULATIONS IN PRECISION MEDICINE: A FEDERATED TRANSFER LEARNING APPROACH. | Li BS et al. | β | 2023 | β |
| The Future of AI and Informatics in Radiology: 10 Predictions. | Langlotz CP | β | 2023 | β |
| Who has skin in the game? Expanding patient opportunities for research engagement is a win-win for dermatology. | Colvin A et al. | β | 2023 | β |
| Biobanking as a Tool for Genomic Research: From Allele Frequencies to Cross-Ancestry Association Studies. | Lazareva TE et al. | β | 2022 | β |
| Disparities in Clinical Trial Participation: Multilevel Opportunities for Improvement. | Stewart BA et al. | β | 2022 | β |
| Enhanced rare disease mapping for phenome-wide genetic association in the UK Biobank. | Patrick MT et al. | β | 2022 | β |
| Enrichment analyses identify shared associations for 25 quantitative traits in over 600,000 individuals from seven diverse ancestries. | Smith SP et al. | β | 2022 | β |
| Ethical challenges of precision cancer medicine. | Winkler EC et al. | β | 2022 | β |
| Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options. | Koleva-Kolarova R et al. | β | 2022 | β |
| Identification of a Prognostic Microenvironment-Related Gene Signature in Glioblastoma Patients Treated with Carmustine Wafers. | Manini I et al. | β | 2022 | β |
| Mass spectrometry based high-throughput bioanalysis of low molecular weight compounds: are we ready to support personalized medicine? | Bravo-Veyrat S et al. | β | 2022 | β |
| Multidisciplinary Effort to Drive Precision-Medicine for the Future. | Kong D et al. | β | 2022 | β |
| New Drug Development and Clinical Trial Design by Applying Genomic Information Management. | Ko YK et al. | β | 2022 | β |
| Precision medicine via the integration of phenotype-genotype information in neonatal genome project. | Dong X et al. | β | 2022 | β |
| Research on Digital Technology Use in Cardiology: Bibliometric Analysis. | Yeung AWK et al. | β | 2022 | β |
| Sequre: a high-performance framework for rapid development of secure bioinformatics pipelines. | SmajloviΔ H et al. | β | 2022 | β |
| Social Epigenomics: Conceptualizations and Considerations for Oral Health. | Gomaa N | β | 2022 | β |
| What can data trusts for health research learn from participatory governance in biobanks? | Milne R et al. | β | 2022 | β |
| A Comparison of Serum and Plasma Blood Collection Tubes for the Integration of Epidemiological and Metabolomics Data. | Sotelo-Orozco J et al. | β | 2021 | β |
| Anticipatory Governance in Biobanking: Security and Risk Management in Digital Health. | RychnovskΓ‘ D | β | 2021 | β |
| Artificial Intelligence in the Healthcare System: An Overview. | Lorkowski J et al. | β | 2021 | β |
| Attitudes toward genomics and precision medicine. | DuBois JM et al. | β | 2021 | β |
| Avoiding "toxic knowledge": the importance of framing personalized risk information in clinical decision-making. | Kostick KM et al. | β | 2021 | β |
| [Complexity theory and the hypertensive patient]. | Barochiner J | β | 2021 | β |
| Considerations for an integrated population health databank in Africa: lessons from global best practices | Igumbor JO et al. | β | 2021 | β |
| Considerations for an integrated population health databank in Africa: lessons from global best practices. | Igumbor JO et al. | β | 2021 | β |
| Cross-ancestry genome-wide association studies identified heterogeneous loci associated with differences of allele frequency and regulome tagging between participants of European descent and other ancestry groups from the UK Biobank. | De Lillo A et al. | β | 2021 | β |
| Genetics of coronary artery disease in the post-GWAS era. | Chen Z et al. | β | 2021 | β |
| GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease. | Leysen H et al. | β | 2021 | β |
| How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies. | Gallon R et al. | β | 2021 | β |
| Including Digital Sequence Data in the Nagoya Protocol Can Promote Data Sharing. | Ambler J et al. | β | 2021 | β |
| Oral cancer: changing the aim of the biopsy in the age of precision medicine. A review. | Bruschini R et al. | β | 2021 | β |
| Overcoming Disparities in Cancer: A Need for Meaningful Reform for Hispanic and Latino Cancer Survivors. | Kronenfeld JP et al. | β | 2021 | β |
| Practices and Attitudes toward Returning Genomic Research Results to Low-Resource Research Participants. | Raymond MB et al. | β | 2021 | β |
| Precision Medicine: Making It Happen for Malaysia. | Jamal ARA | β | 2021 | β |
| Prostate cancer patients' self-reported participation in research: an examination of racial/ethnic disparities. | Palmer NR et al. | β | 2021 | β |
| Public Attitudes to Digital Health Research Repositories: Cross-sectional International Survey. | Nunes Vilaza G et al. | β | 2021 | β |
| Racial, ethnic, and gender differences in obesity and body fat distribution: An All of Us Research Program demonstration project. | Karnes JH et al. | β | 2021 | β |
| Strategies to Uplift Novel Mendelian Gene Discovery for Improved Clinical Outcomes. | Seaby EG et al. | β | 2021 | β |
| The Ethics of Consent in a Shifting Genomic Ecosystem. | Lee SS | β | 2021 | β |
| The Impact of Communicating Uncertainty on Public Responses to Precision Medicine Research. | Ratcliff CL et al. | β | 2021 | β |
| The Need for a Human Pangenome Reference Sequence. | Miga KH et al. | β | 2021 | β |
| Toward dynamic phenotypes and the scalable measurement of human behavior. | Germine L et al. | β | 2021 | β |
| African American mothers' attitudes towards genetic testing in the InterGEN study. | Wright ML et al. | β | 2020 | β |
| Approach to High Volume Enrollment in Clinical Research: Experiences from an All of Us Research Program Site. | Ilori TO et al. | β | 2020 | β |
| A roadmap for precision medicine research recruitment: empirical assessment of the public's willingnessΒ to participate. | Moriarty K et al. | β | 2020 | β |
| At the crossroads of oral health inequities and precision public health. | Gansky SA et al. | β | 2020 | β |
| Can Precision Medicine Actually Help People Like Me? African American and Hispanic Perspectives on the Benefits and Barriers of Precision Medicine. | Yeh VM et al. | β | 2020 | β |
| Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening. | Offit K et al. | β | 2020 | β |
| Challenges in the diagnosis and discovery of rare genetic disorders using contemporary sequencing technologies. | Seaby EG et al. | β | 2020 | β |
| Developing pathways for community-led research with big data: a content analysis of stakeholder interviews. | Grayson S et al. | β | 2020 | β |
| Discovery and quality analysis of a comprehensive set of structural variants and short tandem repeats. | Jakubosky D et al. | β | 2020 | β |
| Donor genetic backgrounds contribute to the functional heterogeneity of stem cells and clinical outcomes. | Wang T et al. | β | 2020 | β |
| Electronic health records and polygenic risk scores for predicting disease risk. | Li R et al. | β | 2020 | β |
| Ethical, Legal, and Social Issues Related to the Inclusion of Individuals With Intellectual Disabilities in Electronic Health Record Research: Scoping Review. | Raspa M et al. | β | 2020 | β |
| Fostering Ethical, Legal, and Social Implications Research in Tribal Communities: The Center for the Ethics of Indigenous Genomic Research. | Hiratsuka VY et al. | β | 2020 | β |
| From the Roman Empire to the New Millennium. Data access and sharing from healthy ageing cohorts. | Gambaro E et al. | β | 2020 | β |
| Genetic underpinnings of cerebral edema in acute brain injury: an opportunity for pathway discovery. | Kirsch E et al. | β | 2020 | β |
| Genetic Variation and Response to Neurocritical Illness: a Powerful Approach to Identify Novel Pathophysiological Mechanisms and Therapeutic Targets. | Acosta JN et al. | β | 2020 | β |
| Importance of Genetic Studies of Cardiometabolic Disease in Diverse Populations. | FernΓ‘ndez-Rhodes L et al. | β | 2020 | β |
| Information Loss in Harmonizing Granular Race and Ethnicity Data: Descriptive Study of Standards. | Wang K et al. | β | 2020 | β |
| Innovations in research and clinical care using patient-generated health data. | Jim HSL et al. | β | 2020 | β |
| Interdisciplinary and Transdisciplinary Perspectives: On the Road to a Holistic Approach to Dementia Prevention and Care. | Rodriguez Then FS et al. | β | 2020 | β |
| Involving research participants in a pan-European research initiative: the EPAD participant panel experience. | Gregory S et al. | β | 2020 | β |
| Multi-Ethnic Genome-Wide Association Study of Decomposed Cardioelectric Phenotypes Illustrates Strategies to Identify and Characterize Evidence of Shared Genetic Effects for Complex Traits. | Baldassari AR et al. | β | 2020 | β |
| Parental Attitudes toward Artificial Intelligence-Driven Precision Medicine Technologies in Pediatric Healthcare. | Sisk BA et al. | β | 2020 | β |
| Participant-Centered Strategies for Overcoming Barriers to Biospecimen Collection among Spanish-Speaking Latina Breast Cancer Survivors. | Samayoa C et al. | β | 2020 | β |
| Perspectives on Precision Medicine in a Tribally Managed Primary Care Setting. | Beans JA et al. | β | 2020 | β |
| Polygenic Risk Scores in Coronary Artery Disease and Atrial Fibrillation. | Gladding PA et al. | β | 2020 | β |
| Precision health: a primer for physiotherapists. | Dickson C et al. | β | 2020 | β |
| Precision (Personalized) Nutrition: Understanding Metabolic Heterogeneity. | Zeisel SH | β | 2020 | β |
| Prognostic significance of the Controlling Nutritional Status (CONUT) score in surgically treated breast cancer patients. | Huang ZZ et al. | β | 2020 | β |
| Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes. | Ilan Y | β | 2020 | β |
| Soft windowing application to improve analysis of high-throughput phenotyping data. | Haselimashhadi H et al. | β | 2020 | β |
| The application of big data to cardiovascular disease: paths to precision medicine. | Leopold JA et al. | β | 2020 | β |
| The promise and reality of therapeutic discovery from large cohorts. | Melamud E et al. | β | 2020 | β |
| Unlocking Personalized Biomedicine and Drug Discovery with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Fit for Purpose or Forever Elusive? | de Korte T et al. | β | 2020 | β |
| Artificial Intelligence and Personalized Medicine. | Schork NJ | β | 2019 | β |
| Artificial intelligence for precision medicine in neurodevelopmental disorders. | Uddin M et al. | β | 2019 | β |
| Artificial intelligence in clinical and genomic diagnostics. | Dias R et al. | β | 2019 | β |
| Big science and big data in nephrology. | Saez-Rodriguez J et al. | β | 2019 | β |
| Comparison of On-Site Versus Remote Mobile Device Support in the Framingham Heart Study Using the Health eHeart Study for Digital Follow-up: Randomized Pilot Study Set Within an Observational Study Design. | Spartano NL et al. | β | 2019 | β |
| Data model harmonization for the All Of Us Research Program: Transforming i2b2 data into the OMOP common data model. | Klann JG et al. | β | 2019 | β |
| Difficulties and challenges in the development of precision medicine. | Liu X et al. | β | 2019 | β |
| Earth Observation: Investigating Noncommunicable Diseases from Space. | Jia P et al. | β | 2019 | β |
| Emerging technologies towards enhancing privacy in genomic data sharing. | Berger B et al. | β | 2019 | β |
| Exploring Understanding of "Understanding": The Paradigm Case of Biobank Consent Comprehension. | Beskow LM et al. | β | 2019 | β |
| How Biomedical HIV Prevention Trials Incorporate Behavioral and Social Sciences Research: A Typology of Approaches. | Corneli A et al. | β | 2019 | β |
| How current reporting practices may mask differences: A call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trials. | Borno HT et al. | β | 2019 | β |
| "I don't want to be Henrietta Lacks": diverse patient perspectives on donating biospecimens for precision medicine research. | Lee SS et al. | β | 2019 | β |
| Improving the phenotype risk score as a scalable approach to identifying patients with Mendelian disease. | Bastarache L et al. | β | 2019 | β |
| Mitochondrial DNA, nuclear context, and the risk for carcinogenesis. | Kaufman BA et al. | β | 2019 | β |
| Moving Toward a Precision-Based, Personalized Framework for Prevention Science: Introduction to the Special Issue. | August GJ et al. | β | 2019 | β |
| Optimizing Precision Medicine for Public Health. | Bilkey GA et al. | β | 2019 | β |
| Perspectives on communication and engagement with regard to collecting biospecimens and family health histories for cancer research in a rural Alaska Native community. | Dirks LG et al. | β | 2019 | β |
| Pilot GWAS of caries in African-Americans shows genetic heterogeneity. | Orlova E et al. | β | 2019 | β |
| Precision Medicine Research: An Exception or An Exemplar? | Largent EA | β | 2019 | β |
| Precision Strategies as a Timely and Unifying Framework for Ongoing Prevention Science Advances. | Ridenour TA | β | 2019 | β |
| Real world data as a key element in precision medicine for lymphoid malignancies: potentials and pitfalls. | El-Galaly TC et al. | β | 2019 | β |
| Sepsis: Precision-Based Medicine for Pregnancy and the Puerperium. | Greer O et al. | β | 2019 | β |
| Single-Cell RNA Sequencing-Based Computational Analysis to Describe Disease Heterogeneity. | Zeng T et al. | β | 2019 | β |
| The authors reply. | Saez-Rodriguez J et al. | β | 2019 | β |
| The Era of the Genome and Dental Medicine. | Divaris K | β | 2019 | β |
| The Role of Participants in a Medical Information Commons. | Majumder MA et al. | β | 2019 | β |
| The role of the doctor in precision medicine. | Almeida TF | β | 2019 | β |
| Trust and Expectations of Researchers and Public Health Departments for the Use of HIV Molecular Epidemiology. | Schairer CE et al. | β | 2019 | β |
| What is genomic medicine? | Roth SC | β | 2019 | β |
| An NF-ΞΊB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells. | Ius T et al. | β | 2018 | β |
| Characteristics Of Likely Precision Medicine Initiative Participants Drawn From A Large Blood Donor Population. | Bloss CS et al. | β | 2018 | β |
| Clinical Pharmacogenetics for Precision Medicine: Successes and Setbacks. | Chambliss AB et al. | β | 2018 | β |
| Combining distributed regression and propensity scores: a doubly privacy-protecting analytic method for multicenter research. | Toh S et al. | β | 2018 | β |
| Community Partnership in Precision Medicine: Themes from a Community Engagement Conference. | Jones L et al. | β | 2018 | β |
| Folate-receptor-targeted laser-activable poly(lactide-<i>co</i>-glycolic acid) nanoparticles loaded with paclitaxel/indocyanine green for photoacoustic/ultrasound imaging and chemo/photothermal therapy. | Liu F et al. | β | 2018 | β |
| Genomics and electronic health record systems. | Ohno-Machado L et al. | β | 2018 | β |
| How Should Biobanks Prioritize and Diversify Biosample Collections? A 40-Year Scientific Publication Trend Analysis by the Type of Biosample. | Lee JE et al. | β | 2018 | β |
| Improving -Omics-Based Research and Precision Health in Minority Populations: Recommendations for Nurse Scientists. | Taylor JY et al. | β | 2018 | β |
| Informed Consent in Translational Genomics: Insufficient Without Trustworthy Governance. | Burke W et al. | β | 2018 | β |
| mActive-Smoke: A Prospective Observational Study Using Mobile Health Tools to Assess the Association of Physical Activity With Smoking Urges. | Silverman-Lloyd LG et al. | β | 2018 | β |
| Periodontal profile classes predict periodontal disease progression and tooth loss. | Morelli T et al. | β | 2018 | β |
| PRECISION MEDICINE: FROM DIPLOTYPES TO DISPARITIES TOWARDS IMPROVED HEALTH AND THERAPIES. | Crawford DC et al. | β | 2018 | β |
| Reflecting health: smart mirrors for personalized medicine. | Miotto R et al. | β | 2018 | β |
| Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes. | Gregory S et al. | β | 2018 | β |
| Research participation preferences as expressed through a patient portal: implications of demographic characteristics. | Obeid JS et al. | β | 2018 | β |
| The Evolution of Public Health Genomics: Exploring Its Past, Present, and Future. | Molster CM et al. | β | 2018 | β |
| The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants. | Serretti A | β | 2018 | β |
| Wearables and the medical revolution. | Dunn J et al. | β | 2018 | β |
| Willingness to Participate in a National Precision Medicine Cohort: Attitudes of Chronic Kidney Disease Patients at a Cleveland Public Hospital. | Cooke Bailey JN et al. | β | 2018 | β |
| Working Together to Address Women's Health in Research and Drug Development: Summary of the 2017 Women's Health Congress Preconference Symposium. | Feuerstein IM et al. | β | 2018 | β |
| Analysis commons, a team approach to discovery in a big-data environment for genetic epidemiology. | Brody JA et al. | β | 2017 | β |
| Are We There Yet? Human Factors Knowledge and Health Information Technology - the Challenges of Implementation and Impact. | Turner P et al. | β | 2017 | β |
| Conclusion: Special issue on genetic and alcohol use disorder research with diverse racial/ethnic groups: Key findings and potential next steps. | Chartier KG et al. | β | 2017 | β |
| Individual-specific edge-network analysis for disease prediction. | Yu X et al. | β | 2017 | β |
| Participatory Genomic Research: Ethical Issues from the Bottom Up to the Top Down. | Aungst H et al. | β | 2017 | β |
| Precisely Where Are We Going? Charting the New Terrain of Precision Prevention. | Meagher KM et al. | β | 2017 | β |
| Precision Dentistry in Early Childhood: The Central Role of Genomics. | Divaris K | β | 2017 | β |
| Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know? | Seripa D et al. | β | 2017 | β |
| The experience of physicians in pharmacogenomic clinical decision support within eight German university hospitals. | Hinderer M et al. | β | 2017 | β |